5 completed. 2 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow disufenton sodium: new trials by email Literature Review of disufenton sodium trials Research Report on disufenton sodium
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma OKN-007, Temozolomide (TMZ) - Recurrent Malignant Glioma, Brain Glioblastoma | Phase 2 | Completed | Oblato, Inc. | 57 | 2020-06-12 | 2025-08-12 |
| Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of HPN-07 and HPN-07 Plus NAC HPN-07, NAC, Placebo - Hearing Loss, Sensorineural Hearing Loss | Phase 1 | Completed | Otologic Pharmaceutics, Inc. | 32 | 2014-10-01 | 2015-05-01 |
| Safety of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke NXY-059 - Intracerebral Hemorrhage | Phase 2 | Completed | AstraZeneca | 600 | 2004-08-01 | 2013-01-04 |
| Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke NXY-059 - Cerebral Stroke, Ischemic Attack, Transient | Phase 3 | Completed | AstraZeneca | 1700 | 2003-06-01 | 2010-11-15 |
| Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke NXY-059 - Cerebral Stroke, Stroke, Acute | Phase 3 | Completed | AstraZeneca | 3200 | 2003-05-01 | 2010-11-15 |
Stroke (3) · Cataplexy (2) · Hemorrhage (2) · Ischemic Attack, Transient (2) · Cerebral Hemorrhage (1) · Glioma (1) · Hearing Loss (1) · Hearing Loss, Noise-Induced (1) · Hearing Loss, Sensorineural (1) · Ischemia (1)
AstraZeneca (3) · Oblato, Inc. (1) · Otologic Pharmaceutics, Inc. (1)
United States (4) · United Kingdom (2) · Argentina (1) · Australia (1) · Austria (1) · Belgium (1) · Brazil (1) · Bulgaria (1) · Canada (1) · Chile (1) · China (1) · Czechia (1) · France (1) · Germany (1) · Greece (1)
Treva Tyson, MD (1)